Clinical Trials Logo

Chronic Disease clinical trials

View clinical trials related to Chronic Disease.

Filter by:

NCT ID: NCT03062670 Completed - Chronic Disease Clinical Trials

Team-Based Delivery of Care in Outpatient Settings

Start date: January 31, 2017
Phase: N/A
Study type: Interventional

Through this research we intend to evaluate whether a team-based care delivery approach using daily huddles is effective in improving caregiver and patient outcomes in primary care setting. This approach is expected to not only lead to effective primary care delivery outcomes, but also result in greater team morale, reduced burnout, and a higher rate of innovation.

NCT ID: NCT03055988 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Cardiovascular Function in COPD Patients

Start date: March 29, 2017
Phase: Phase 4
Study type: Interventional

The objectives of the study are to explore the effect of treatment with tiotropium + olodaterol fixed dose combination (FDC) compared to fluticasone propionate + salmeterol FDC on: - reversal of left ventricular diastolic dysfunction assessed with cardiac magnetic resonance (CMR) imaging, - measures of arterial stiffness assessed by CMR and pulse wave analysis (PWA), - reduction of hyperinflation assessed with body plethysmography and - post dose spirometry.

NCT ID: NCT03052959 Completed - Clinical trials for Cancer and Chronic Disease Prevention

BETTER HEALTH: Durham

Start date: October 2, 2017
Phase: N/A
Study type: Interventional

The BETTER intervention consists of supportive meetings between a specially trained prevention practitioner nurse and individuals aged 40-64 years to review recommended chronic disease prevention and screening activities (CDPS). The prevention practitioner nurse will assist participants to identify goals for accomplishing CDPS activities in the next 6 months. Promotion, recruitment of participants and delivery of the BETTER intervention will be adapted to meet the needs of the residents through the use of participatory research methods and community engagement strategies. The study population consists of individuals aged 40-64 years living in 10 designated areas or "clusters" within Durham Region in Oshawa and Whitby. Objectives: 1. Help people in the designated areas identify personal goals related to chronic disease prevention and screening activities. 2. Evaluate whether the prevention practitioner was effective in helping people achieve their goals and explore whether this type of intervention could work in other settings. 3. Share what the investigators learn with government and other public health units in Ontario and across Canada. Some clusters will receive the BETTER intervention right away and other clusters will be in a wait-list control group to receive the intervention 6 months later. Our main outcome is the change in a score that considers the number of preventive health items a person has achieved during the 6 months. The investigators will also be doing in-depth interviews and focus groups with health care providers, community organizations and people who live in the designated areas to understand whether the primary practitioner was effective.

NCT ID: NCT03036189 Completed - Chronic Disease Clinical Trials

Improving Chronic Illness Management With the Apsaalooke Nation: The Baa Nnilah Project

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This is a group randomized trial of an intervention to improve chronic illness self-management.

NCT ID: NCT03034993 Completed - Chronic Disease Clinical Trials

Self-Management Using Text Messaging in a Homeless Population

Start date: July 21, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if an automated text message intervention is beneficial for homeless patients in reducing their hospital visits, increasing their primary care appointments, and help them increase medication adherence.

NCT ID: NCT03030638 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Drug Utilization Study for Olodaterol

Start date: February 8, 2017
Phase:
Study type: Observational

This study aims to characterise the use of single-agent olodaterol and single-agent indacaterol, the only marketed long-acting beta2-agonist (LABA)s authorised for chronic obstructive pulmonary disease (COPD), but not for asthma, in clinical practice.

NCT ID: NCT03030313 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Respiration Rate Monitoring in COPD Patients

Start date: December 1, 2016
Phase: N/A
Study type: Interventional

Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.

NCT ID: NCT03028207 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Cross-sectional Study on COPD Prevalence

Start date: March 9, 2017
Phase:
Study type: Observational

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality worldwide and hence, estimating its prevalence is important. Since 2007, there are few data on the prevalence of COPD in the general population in Spain. The main objective of this epidemiological observational study is to estimate the prevalence of COPD in residents of Spain among the population over 40 years of age. The subjects will be distributed in two groups depending on the presence and absence of COPD. The study will have a single visit in which a brief interview will take place and subjects will need to complete the medical tests the case report form with a series of questionnaires. No drugs will be administered in this study.

NCT ID: NCT03017196 Completed - Chronic Disease Clinical Trials

My Life, My Healthcare

Start date: January 2017
Phase: N/A
Study type: Interventional

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare teams' care experience and communication, while reducing patient treatment burden?" Through implementation of the My Life, My Healthcare Discussion Aid for patients with chronic conditions, the study team hypothesizes that it will be feasible to implement in routine primary care practice and positively impact patient and healthcare teams experience of chronic care, while reducing patient treatment burden.

NCT ID: NCT03013725 Completed - Chronic Disease Clinical Trials

The Hordaland Health Study

HUSK
Start date: January 1992
Phase: N/A
Study type: Observational

The Hordaland Health Studies (HHS) were conducted in 1992-93 (The Homocysteine study) and in 1997-99 (HUSK). Both surveys were conducted as a joint project between the University of Bergen, the Norwegian Health Screening Service (SHUS) (now part of the National Institute of Public Health) and the Municipal Health Service in Hordaland. The main focus of the studies is on chronic diseases including cardiovascular disease, cancer, osteoporosis, anxiety and depression. Some projects focus on psychosocial factors, occupational research, musculoskeletal diseases, urinary incontinence and mapping of drug use. The main purpose of the surveys is to gather information so that disease ultimately can be prevented. Approximately 36,000 residents of Hordaland county participated in the studies, ca. 18,000 in 1992-93 and ca. 26,000 in 1997-99. About 7,000 of those who participated in the 1992-93 survey also participated in 1997-99.